周建华 - 中山大学 - 肿瘤防治中心

个人简介

2001年中山医科大学本科毕业后一直在中山大学肿瘤防治中心超声科工作， 2009年获中山大学临床医学博士学位，2009和2014年赴美国杰弗逊大学医学院和斯坦福大学医学院分子影像实验室从事合作研究。2009年入选中山大学肿瘤防治中心首批优秀青年人才，2012年被评为广州市珠江科技新星，2013年入选教育部新世纪优秀人才支持计划，2018年入选广东省杰出青年医学人才。擅长肝胆、泌尿系、乳腺、甲状腺、淋巴结等肿瘤的超声诊断及介入诊断治疗，在肝脏、甲状腺结节、乳腺结节和淋巴结的介入诊断与消融微创治疗方面具有丰富经验。教育学习经历 1996年9月—2001年6月中山医科大学　本科 2001年9月—2005年12月中山大学硕士研究生导师：吴沛宏教授 2006年9月—2009年6月中山大学博士研究生导师：吴沛宏教授 2009年9月—2010年8月美国杰弗逊大学医学院　指导老师：刘吉斌教授 2014年11月—2015年12月美国斯坦福大学　指导老师：Juergen Willmann 工作简历 2001年7月——2006年12月　中山大学肿瘤防治中心医师 2007年1月——2010年12月　中山大学肿瘤防治中心主治医师 2011年1月——2017年12月　中山大学肿瘤防治中心副主任医师 2018年1月起中山大学肿瘤防治中心主任医师

研究领域

擅长肝胆、泌尿系、乳腺、甲状腺、淋巴结等肿瘤的超声诊断及介入诊断治疗，在肝脏病变、甲状腺结节、乳腺结节和淋巴结病变的介入诊断与消融微创治疗方面具有丰富经验

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Zheng X, Yao Z., Huang Y, Yu Y, Wang Y, Liu Y, Mao R, Li F, Xiao Y, Wang Y, Hu Y, Yu J, Zhou J*. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nature Communications 2020; 11(1), pp.1-9. *Corresponding Author Zheng W, Li Q, Zou XB, Wang JW, Han F, Li F, Huang LS, Li AH, Zhou JH*. Evaluation of Contrast-Enhanced Ultrasound LI-RADS v2017: Application on 2,020 Liver Nodules in Patients with Hepatitis B Infection. Radiology 2020; 294:299–307. *Corresponding Author Zhou J*, Wang H, Zhang H, Lutz AM, Tian L, Hristov D, Willmann JK. VEGFR2-Targeted Three-Dimensional Ultrasound Imaging Can Predict Responses to Antiangiogenic Therapy in Preclinical Models of Colon Cancer. Cancer Res 2016 76 (14): 4081-4089. Zhou JH, Cao LH, Liu JB, Zheng W, Liu M, Luo RZ, Han F, Li AH. Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US. Radiology 2011; 259(5):406-413. Zhou J, Zhang H, Wang H, Lutz AM, El Kaffas A, Tian L, Hristov D, Willmann JK. Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging. Angiogenesis 2017;20(4):547-555. Chen Y, Han F, Cao LH, Li C, Wang JW, Li Q, Zheng W, Guo ZX, Li AH, Zhou JH*. Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound. BMC Cancer 2015;15:136 . *Corresponding Author Lin CY, Cao LH, Wang JW, Zheng W, Chen Y, Feng ZZ, Li AH, Zhou JH*. Ultrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound. BMC Cancer 2013;13:302. *Corresponding Author Liu Y, Chen S, Zheng C, Ding M, Zhang L, Wang L, Xie M, Zhou JH*. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. BMC Cancer 2017 ; 17:285. *Corresponding Author Li F, Han J, Han F, Wang JW, Luo RZ, Li AH, Zhou JH*. Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: PotentialRole of Contrast-Enhanced Ultrasound in Diagnosis. AJR Am J Roentgenol 2017;209(4):767-77.*Corresponding Author Zhou JH, Cao LH, Zheng W, Liu M, Han F, Li AH. Contrast-enhanced gray-scale ultrasound for quantitative evaluation of tumor response to chemotherapy: preliminary results with a mouse hepatoma model. AJR Am J Roentgenol 2011; 196(1):W13-W17. Han J, Liu YB, Han F, Li Q, Yan CJ, Zheng W, Wang JW, Guo ZX, Wang J, Li AH, Zhou JH*. The degree of contrast washout on contrast-enhanced ultrasound in distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Ultrasound Med Biol 2015, 41(12):3088-95. *Corresponding Author Wang JW, Zheng W, Liu JB, Chen Y, Cao LH, Luo RZ, Li AH, Zhou JH*. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts. PLoS One 2013; 8(3):e58274. *Corresponding Author Zhou JH, Zheng W, Cao LH, Liu M, Luo RZ, Han F, Wu PH, Li AH. Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment. Eur J Radiol 2012；81(6)：1360-1365. Zhou JH, Zheng W, Cao LH, Liu M, Luo RZ, Han F, Wu PH, Li AH. Quantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomide. Br J Radiol 2011; 84(9):826-832. Wang JW, Zheng W, Chen Y, Cao LH, Luo RZ, Li AH, Zhou JH*. Quantitative assessment of tumor blood flow changes in a murine breast cancer model after adriamycin chemotherapy using contrast-enhanced destruction-replenishment sonography. J Ultrasound Med. 2013; 32(4):683-90. *Corresponding Author Zhou JH, Zheng W, Cao LH, Liu M, Han F, Li AH. Antiangiogenic tumor treatment noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound. Acad Radiol 2010; 17(5):646-651. Zhou JH, Li AH, Cao LH, Jiang HH, Liu LZ, Pei XQ, Han F. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: the assessment using contrast-enhanced ultrasound. Br J Radiol 2008; 81(2):113-119. Dave JK, Halldorsdottir VG, Eisenbrey JR, Merton DA, Liu JB, Zhou JH, Wang HK, Park S, Dianis S, Chalek CL, Lin F, Thomenius KE, Brown DB, Forsberg F. Investigating the efficacy of subharmonic aided pressure estimation for portal vein pressures and portal hypertension monitoring. Ultrasound Med Biol 2012;38(10):1784-98. Dave JK, Halldorsdottir VG, Eisenbrey JR, Liu JB, Lin F, Zhou JH, Wang HK, Thomenius KE, Forsberg F. In vivo subharmonic pressure estimation of portal hypertension in canines. Ultrasonics Symposium (IUS), 2010 IEEE; 778-781. Yubo Liu, Yini Huang, Jing Han, Jianwei Wang, Fei Li, Jianhua Zhou. Association Between ShearWave Elastography of Virtual Touch Tissue Imaging Quantification Parameters andthe Ki-67 Proliferation Status in Luminal-Type Breast Cancer. J Ultrasound Med. 2019 38(1):73-80. *Corresponding Author